SCHEMBL23159261

SCHEMBL23159261

CC(CC1CC1c1nc([C@H](C)C(C)C)ccc1Cl)[C@H](C)c1ccc(Cl)c(C2CC2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17069222 0.83 SCN9A (0.32) —
SCHEMBL17069230 0.83 SCN9A (0.32) —
SCHEMBL16771234 0.71 SCN9A (0.33) —
SCHEMBL17062222 0.70 SCN9A (0.37) —
SCHEMBL16770731 0.69 PPARA (0.32) —
SCHEMBL16770636 0.69 PPARA (0.32) —
SCHEMBL28209656 0.60 PDE10A (0.38) —
SCHEMBL18400082 0.59 OPRL1 (0.32) —
SCHEMBL23005924 0.56 S1PR3 (0.41) —
SCHEMBL21212184 0.55 TRPV3 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210093618-A1 SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2021-04-01 — — US disclosed
Send feedback